Dysbiosis in aspirin‐exacerbated respiratory disease

Saved in:
Bibliographic Details
Published inInternational forum of allergy & rhinology Vol. 11; no. 7; pp. 1116 - 1120
Main Authors Cook, Kevin A., Domissy, Alain, Simon, Ronald A., White, Andrew A., Modena, Brian D.
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.07.2021
Subjects
Aspirin
aspirin‐exacerbated respiratory disease
Asthma
chronic rhinosinusitis
Dysbacteriosis
dysbiosis
microbiome
nasal polyposis
nasal polyps
Respiratory diseases
Rhinitis
Sinusitis
aspirin-exacerbated respiratory disease
chronic rhinosinusitis
nasal polyps
asthma
microbiome
nasal polyposis
dysbiosis
Online AccessGet full text

Cover

More Information
Bibliography:Potential conflict of interest: B.D.M. receives research support from the National Institutes of Health and from Self Care Catalysts and Propeller Health; he has participated in advisory boards and/or speaker bureaus for the following companies: AstraZeneca, Circassia, Teva, Regeneron, and Sanofi. A.A.W. is a board member of the Western Society of Allergy, Asthma and Immunology and on the editorial board of the
View this article online at wileyonlinelibrary.com.
he has participated as a consultant for Optinose, AstraZeneca, and ALK‐Abelló A/S, and in speaker bureaus for the following companies: AstraZeneca, Regeneron, and Sanofi. K.A.C. has participated in the advisory board for Regeneron/Sanofi. All other authors have nothing relevant to disclose.
American Journal of Rhinology and Allergy
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2042-6976
2042-6984
DOI:10.1002/alr.22762